Magnis Energy Technologies (ASX:MNS) - Chairman, Frank Poullas
Chairman, Frank Poullas
Source: Peak Asset Management
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Magnis Energy (MNS) shares have slipped following media reports its chairman is under investigation by ASIC
  • The chairman of Magnis Energy, Frank Poullas, is being investigated by the corporate regulator, according to a report from The Australian
  • Magnis, in an announcement to the market, has said the company is not under investigation by ASIC
  • Magnis Energy’s share price has fallen 17.9 per cent to 55 cents per share at 3:15 pm AEDT after the company’s worth increased by 81 per cent in the previous month
  • According to the article, the Australian Federal Police has assisted ASIC in its inquiries, with the latter having previously discussed MNS with the ASX

Magnis Energy (MNS) shares have slipped following media reports its chairman is under investigation by the Australian Securities and Investments Commission (ASIC).

The chairman of Magnis Energy, Frank Poullas, is being investigated by the corporate regulator, according to a report from The Australian.

According to the article, the Australian Federal Police has assisted ASIC in its inquiries, with the latter having previously discussed MNS with the ASX.

Not only does ASIC have its gaze set upon Mr Poullas, but the article said a source “close” to ASIC has not ruled out expanding the probe to include the company.

Magnis, in an announcement to the market, has said the company is not under investigation by ASIC. The company did not confirm or deny if Mr Poullas is under investigation.

“The media article contains a number of unsubstantiated statements regarding the company,” MNS said in an announcement.

“The media article repeats previously published speculation concerning trading in the company’s shares and inquiries undertaken by ASIC in relation to some trading in those shares, the company is not aware of any material which would indicate that the company is or is likely to be under any form of investigation.”

Magnis Energy’s share price has fallen 17.9 per cent to 55 cents per share at 3:15 pm AEDT after the company’s worth increased by 81 per cent in the previous month

ASIC has already sought to discourage market participants from driving up the Magnis share price, infiltrating a Telegram channel of 400 traders in October and alerting them that they might be breaching the law with a coordinated “pump-and-dump” effort.

The Market Herald is not suggesting Mr Poullas is involved in this activity.

On Monday Mr Poullas received 500,000 ordinary shares, worth nearly $335,000, triggered after the company reached a $500 million market capitalisation milestone.

The ASX is thought to have opted against releasing a Magnis Energy statement to the market last week. Instead, the material was published on the company’s website.

An ASX spokesperson declined to comment, saying only that “we do provide guidance to companies that announcements should be material and not for promotional purposes predominately”.

Magnis Energy was contacted for comment.

Magnis Energy’s share price has fallen 14.2 per cent to 57.5 cents per share at 3:10 pm AEDT.

MNS by the numbers
More From The Market Online
The Market Online Video

ASX Market Close: Bourse finishes week on a high as Wisetech pummeled | November 22, 2024

The ASX200 closed up 0.85% at 8,393 points. Economists increasingly expect interest rates in Australia won’t…
The Market Online Video

HotCopper Highlights: Your most watched stocks for Week 47, 2024

In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing,…
Canadian flag

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill…
The Market Online Video

This biotech stock raised $11M in a risk-off environment. Its Alzheimer’s drug could change the game 

Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression…